Europe Home Healthcare Market Overview
Market Size in 2024: USD 106.7 Billion
Market Forecast in 2033: USD 204.4 Billion
Market Growth Rate: 7.5% (2025-2033)
According to the latest report by IMARC Group, the Europe home healthcare market size was valued at USD 106.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 204.4 Billion by 2033, exhibiting a CAGR of 7.5% from 2025-2033.
Europe Home Healthcare Industry Trends and Drivers:
As an aging population and growing load of chronic illnesses call more and more for ongoing, accessible, and individualized care solutions, the European home healthcare industry is showing dynamic expansion. With patients and doctors adopting cost-effective models that guarantee results, healthcare systems are changing their emphasis from institutional treatment to home-based services across the region. The growing integration of sophisticated medical devices and digital health systems that are changing patient monitoring, medication management, and distant diagnostics is helping to strongly support this change. Stakeholders are still investing in scalable solutions that advance preventive care, early intervention, and long-term health management at home as demographic changes become more pronounced. Furthermore supporting the uptake of home healthcare as a major pillar of Europe's changing care continuum, patient preference for familiar surroundings and fewer hospital visits is reinforcing the use of services including skilled nursing, physical therapy, and palliative care.
Particularly via telehealth, wearable devices, and AI-powered monitoring systems, technical progress is greatly improving home healthcare accessibility and performance all across Europe. Healthcare professionals are aggressively using these innovations to facilitate real-time data sharing, customized treatment programs, and better clinical decision-making. In nations with robust infrastructure and good reimbursement policies, such Germany, France, and the Netherlands, this digitization trend is quite apparent since it provides ideal ground for market acceleration. Moreover relieving pressure on hospitals and promoting a more sustainable care model, the expanding ecosystem of home-based diagnostic and treatment choices is helping. By rewarding digital integration and home-based therapies, governments and commercial insurers are reacting, hence accelerating market expansion. Manufacturers are also concentrating on creating small, user-friendly devices to help patients with mobility issues or challenging medical conditions, hence broadening the reach and influence of home healthcare services.
With regionally customized programs to meet particular demographic and healthcare system needs, country-specific projects are helping to strengthen the market's upward path. For instance, home healthcare in the United Kingdom is growing thanks to NHS-supported initiatives pushing for virtual wards and remote patient monitoring. Scandinavian countries are using cross-sector collaboration and digital innovation to provide holistic, patient-centered treatment both in urban and rural areas. Southern European nations are also enhancing public-private collaborations to get around capacity restrictions and raise the quality of service delivery among many groups. These custom treatments are not only speeding access but also helping to increase trust in home-based systems. Europe is placing itself as a world leader in home healthcare innovation and delivery as legislative systems keep changing to support decentralized care, hence clearing the way for persistent market momentum through 2033.
Download sample copy of the Report: https://www.imarcgroup.com/europe-home-healthcare-market/requestsample
Europe Home Healthcare Industry Segmentation:
The report has segmented the market into the following categories:
Analysis by Product:
- Therapeutic Products
- Testing, Screening and Monitoring Products
- Mobility Care Products
Analysis by Service:
- Skilled Nursing
- Rehabilitation Therapy
- Hospice and Palliative Care
- Unskilled Care
- Respiratory Therapy
- Infusion Therapy
- Pregnancy Care
Analysis by Indication:
- Cancer
- Respiratory Diseases
- Movement Disorders
- Cardiovascular Diseases and Hypertension
- Pregnancy
- Wound Care
- Diabetes
- Hearing Disorders
- Others
Country Analysis:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Latest News and Developments:
- November 2024: Heim Health, located in London, secured €2.65 million in a seed funding round led by Heal Capital to improve its software platform for delivering healthcare at home. Founded by Sasha Tory, Kelly Klifa, and James Monico, , Heim Health collaborates with the NHS and private healthcare organizations to optimize community-based care and reduce hospital strain. The funding supports scaling services through digital infrastructure and logistics innovation.
- July 2024: The WHO launched the Strategic Partners’ Initiative for Data and Digital Health (SPI-DDH) to enhance digital health solutions across its 53 European Member States. This initiative aims to address challenges in digital health transformation, including financing, interoperability, and trust in digital solutions. Over 100 representatives from various sectors will collaborate in four specialized working groups focusing on capacity building, home healthcare, interoperability standards, and public health enhancement.
- March 2024: Birdie introduced Flock, a complimentary online and offline community catering to the UK's homecare, live-in, and complex care fields. Flock provides resources, forums, and specialized groups to support knowledge sharing, recruitment, compliance, and policy challenges.
- February 2024: London-based Samphire Neuroscience has raised a pre-seed investment of €2.1 million for its wearable neurostimulation device, Nettle. This is a gadget focused on the alleviation of menstrual discomfort and PMS, utilizing transcranial direct current stimulation (tDCS) to address issues with mood and pain as an innovative, non-invasive approach to women's health. The device seeks to offer a secure, home-based option to conventional therapies.
- January 2024: Rudolf Riester GmbH launched its telemedicine solution, which features the ri-sonic® E-Stethoscope that is integrated with eMurmur® AI for early heart murmur detection. Already used in Europe, the solution supports frontline healthcare, including the "hospital at home" model, to enhance diagnosis and care delivery.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=11416&flag=C
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comments
0 comment